highlighting the importance in future trials to reassess the benefit-risk ratio across different risk profiles within the population with T1D. The mean relative 10-year SRE and SDRN risk scores ...

The ZENITH study found that in high-risk PAH, add-on sotatercept was tied to lower risk for death from any cause, lung ...

“However, results regarding the efficacy of TPE in patients with AAV are conflicting in both randomized controlled trials and case series” The research ... of the risk-benefit ratio before ...

Older adults may benefit from a recently introduced tool that assesses their risk for heart disease, according to a new study ...

While testing of colorectal cancer tumors for mismatch repair (MMR) defects has been recommended for years, the majority of ...

“A relevant increase of the relative risk for a very rare, although severe, condition does not modify the overall risk-benefit ratio of effective ... Experimental and Clinical Biomedical ...

Overall, the risk-benefit ratio is reassuring for people taking ADHD medications." The study was funded by the National Institute for Health and Care Research (NIHR), within the framework of the ...

Patients randomized to EC-D had a 10-year cumulative heart failure risk of 2.1% versus ... the Danish Foundation for Clinical and Experimental Cancer Research, and Sanofi. Jensen disclosed a ...